Healthcare provider profile · identity verified

Austin Thomas Welsh, M.D.

Family Practice · TUCSON, AZ · NPI 1083678650

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Rosuvastatin Calcium	Rosuvastatin Calcium	313	101
Levothyroxine Sodium	Levothyroxine Sodium	264	73
Amlodipine Besylate	Amlodipine Besylate	237	73
Losartan Potassium	Losartan Potassium	236	71
Lisinopril	Lisinopril	235	62
Atorvastatin Calcium	Atorvastatin Calcium	228	65
Gabapentin	Gabapentin	214	69
Metformin Hcl	Metformin Hcl	157	46
Metoprolol Succinate	Metoprolol Succinate	155	45
Trazodone Hcl	Trazodone Hcl	133	45
Tamsulosin Hcl	Tamsulosin Hcl	130	47
Pantoprazole Sodium	Pantoprazole Sodium	117	29
Albuterol Sulfate Hfa	Albuterol Sulfate	111	37
Tramadol Hcl	Tramadol Hcl	111	41
Mirtazapine	Mirtazapine	103	38
Omeprazole	Omeprazole	94	27
Metformin Hcl Er	Metformin Hcl	90	31
Hydrochlorothiazide	Hydrochlorothiazide	78	22
Tizanidine Hcl	Tizanidine Hcl	77	24
Ozempic	Semaglutide	76	16
Allopurinol	Allopurinol	69	20
Eliquis	Apixaban	66	17
Buspirone Hcl	Buspirone Hcl	60	23
Furosemide	Furosemide	60	19
Prednisone	Prednisone	57	30
Fluticasone Propionate	Fluticasone Propionate	56	17
Bupropion Xl	Bupropion Hcl	55	13
Fluconazole	Fluconazole	54	31
Montelukast Sodium	Montelukast Sodium	54	15
Alprazolam	Alprazolam	52	15
Duloxetine Hcl	Duloxetine Hcl	51	17
Ezetimibe	Ezetimibe	50	13
Jardiance	Empagliflozin	50	20
Sertraline Hcl	Sertraline Hcl	50	18
Clopidogrel	Clopidogrel Bisulfate	48	16
Atenolol	Atenolol	47	12
Meloxicam	Meloxicam	46	14
Warfarin Sodium	Warfarin Sodium	46	suppressed
Finasteride	Finasteride	45	14
Mounjaro	Tirzepatide	45	20
Escitalopram Oxalate	Escitalopram Oxalate	44	14
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	44	14
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	42	suppressed
Famotidine	Famotidine	41	18
Hydroxyzine Hcl	Hydroxyzine Hcl	41	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	41	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	39	13
Metoprolol Tartrate	Metoprolol Tartrate	38	12
Simvastatin	Simvastatin	38	13
Venlafaxine Hcl Er	Venlafaxine Hcl	37	suppressed
Spironolactone	Spironolactone	34	12
Doxycycline Monohydrate	Doxycycline Monohydrate	33	22
Pravastatin Sodium	Pravastatin Sodium	33	13
Ropinirole Hcl	Ropinirole Hcl	33	suppressed
Valsartan	Valsartan	32	suppressed
Carvedilol	Carvedilol	31	12
Citalopram Hbr	Citalopram Hydrobromide	31	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	31	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	30	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	30	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	29	23
Chlorthalidone	Chlorthalidone	29	suppressed
Diazepam	Diazepam	29	suppressed
Methylprednisolone	Methylprednisolone	29	suppressed
Ondansetron Hcl	Ondansetron Hcl	28	21
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	28	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	27	15
Lovastatin	Lovastatin	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	27	suppressed
Acyclovir	Acyclovir	26	11
Synthroid	Levothyroxine Sodium	26	11
Venlafaxine Hcl	Venlafaxine Hcl	26	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	25	14
Amiodarone Hcl	Amiodarone Hcl	24	suppressed
Cephalexin	Cephalexin	24	18
Potassium Chloride	Potassium Chloride	24	11
Pregabalin	Pregabalin	21	suppressed
Testosterone Cypionate	Testosterone Cypionate	21	suppressed
Trulicity	Dulaglutide	21	suppressed
Valacyclovir	Valacyclovir Hcl	21	suppressed
Alendronate Sodium	Alendronate Sodium	20	suppressed
Descovy	Emtricitabine/Tenofov Alafenam	20	suppressed
Ibuprofen	Ibuprofen	20	suppressed
Myrbetriq	Mirabegron	20	suppressed
Ondansetron Odt	Ondansetron	20	suppressed
Baclofen	Baclofen	19	suppressed
Celecoxib	Celecoxib	19	suppressed
Lorazepam	Lorazepam	19	suppressed
Methocarbamol	Methocarbamol	19	suppressed
Donepezil Hcl	Donepezil Hcl	18	suppressed
Estradiol	Estradiol	18	suppressed
Mupirocin	Mupirocin	17	13
Oxybutynin Chloride	Oxybutynin Chloride	17	suppressed
Ventolin Hfa	Albuterol Sulfate	17	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	16	suppressed
Irbesartan	Irbesartan	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	13
Terbinafine Hcl	Terbinafine Hcl	16	suppressed
Glipizide Er	Glipizide	15	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Minoxidil	Minoxidil	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Liothyronine Sodium	Liothyronine Sodium	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Azithromycin	Azithromycin	13	suppressed
Nystatin	Nystatin	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	12	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	12	suppressed
Modafinil	Modafinil	12	suppressed
Solifenacin Succinate	Solifenacin Succinate	12	suppressed
Adderall Xr	Dextroamphetamine/Amphetamine	11	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Erythromycin	Erythromycin Base	11	suppressed
Prazosin Hcl	Prazosin Hcl	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Vascepa	Icosapent Ethyl	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error